Treatment with UCN-01 alone or in combination with irinotecan increased the portion of Annexin V-positive cells compared to vehicle-treated cells, in both CRC-SC lines, irrespective of KRAS status. This evidence concerns the gene ANXA5 and colorectal carcinoma.